Clinical Trial Update: A Study of Ceftobiprole in Patients With Fever and Neutropenia. [Phase 3]

View source ↗

Summary

A Phase 3 trial of ceftobiprole in patients with fever and neutropenia was terminated, and the results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-positive Bacterial Infections
• Pseudomonas Infection

Drugs mentioned

• ceftobiprole (ceftobiprole)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Fever, Neutropenia | Phase 3 | Status: TERMINATED | Results posted: 2010-03-29